Oncopeptides News and Activities

Oncopeptides is a company listed under the stock ticker ONCO (SE).

View the org chart displaying its 14 main executives

Most searched biographies at Oncopeptides

• Sofia Heigis, Chief Executive Officer
• Per Samuelsson, Board Member
• Per Wold-Olsen, Chairman of the Board

Create your alert
to follow the executive moves at Oncopeptides.

Oncopeptides has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Oncopeptides

• Oncopeptides submits Type II variation application to EMA for Pepaxti label expansion into third line treatment - Oncopeptides
• First patient enrolled in Oncopeptides’ glioblastoma study - Oncopeptides
• Sofia Heigis presented at Aktiespararna - Oncopeptides
• First patient enrolled in Oncopeptides’ real-world evidence study MARINA in Germany - Oncopeptides
• Oncopeptides to present clinical and translational data on Pepaxti at EHA 2026 in Stockholm - Oncopeptides
• Oncopeptides signs agreement with Salus for distribution and commercialization of Pepaxti in Central and Eastern Europe - Oncopeptides
• Bulletin from the Annual General Meeting in Oncopeptides - Oncopeptides
• Oncopeptides receives formal approval from Norwegian authorities to initiate Window-of-Opportunity study in glioblastoma - Oncopeptides
• Study confirms use of Pepaxti in a broader population, with strong data in the 50% of RRMM patients that suffer from reduced kidney function - Oncopeptides
• Oncopeptalks: Q1 report - Oncopeptides
• View more press releases Close

Social media about Oncopeptides

• Oncopeptides on Wikipedia, Google News & Yahoo Finance
• Oncopeptides on LinkedIn, X (Twitter) & YouTube